JG
NKTR icon

Jefferies Group’s Nektar Therapeutics NKTR Stock Holding History

Jefferies Group’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,351
Closed -$401K – 1758
2022
Q1 		$513K Buy
6,351
+1,569
+33% +$232K ﹤0.01% 1049
2021
Q4 		$969K Buy
+4,782
New +$1.04M 0.01% 1012
2021
Q3 		– Sell
-1,333
Closed -$343K – 1918
2021
Q2 		$343K Buy
+1,333
New +$369K ﹤0.01% 1280
2020
Q1 		– Sell
-3,456
Closed -$1.12M – 2463
2019
Q4 		$1.12M Buy
+3,456
New +$1M 0.01% 1400
2019
Q3 		– Sell
-3,621
Closed -$1.93M – 2923
2019
Q2 		$1.93M Buy
3,621
+3,048
+532% +$1.53M 0.01% 945
2019
Q1 		$289K Buy
+573
New +$340K ﹤0.01% 1811
2018
Q4 		– Sell
-3,206
Closed -$1.94M – 2416
2018
Q3 		$2.93M Buy
3,206
+2,314
+259% +$1.98M 0.02% 801
2018
Q2 		$654K Buy
+892
New +$1.03M ﹤0.01% 1461
2018
Q1 		– Sell
-1,333
Closed -$1.19M – 2563
2017
Q4 		$1.19M Buy
+1,333
New +$788K 0.01% 1254
2016
Q1 		– Sell
-833
Closed -$160K – 2462
2015
Q4 		$211K Sell
833
-740
-47% -$152K ﹤0.01% 1918
2015
Q3 		$259K Buy
+1,573
New +$278K ﹤0.01% 1832
2015
Q1 		– Sell
-3,394
Closed -$698K – 2294
2014
Q4 		$789K Buy
+3,394
New +$725K ﹤0.01% 1083
2014
Q3 		– Sell
-1,831
Closed -$352K – 2333
2014
Q2 		$352K Buy
+1,831
New +$324K ﹤0.01% 1439
2013
Q4 		– Sell
-1,090
Closed -$171K – 2134
2013
Q3 		$171K Sell
1,090
-4,288
-80% -$793K ﹤0.01% 1644
2013
Q2 		$932K Buy
+5,378
New +$825K 0.01% 813

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jefferies Group's NKTR Position: Q2 2022 in Review

Jefferies Group sold out of Nektar Therapeutics (NKTR) in Q2 2022, closing a stake of 6,351 shares — an estimated $401K sold.

Jefferies Group first reported a position in NKTR in Q2 2013 and held it in 15 quarters. The position peaked at $2.93M in Q3 2018. 227 funds tracked by Wall St. Rank hold NKTR as of Q2 2022.

  • Jefferies Group reported no remaining Nektar Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 6,351 Nektar Therapeutics shares in Q2 2022, an estimated $401K.
  • Jefferies Group first reported a position in Nektar Therapeutics in Q2 2013 and held it in 15 quarters.
  • Jefferies Group's Nektar Therapeutics position peaked at $2.93M in Q3 2018.
  • 227 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.